Astellas is a specialty global pharmaceutical company operating in more than 70 countries with cutting-edge research and development and commercialization capabilities around the world.
Our portfolio includes therapies in oncology, urology, immunology, women's health and ophthalmology.
We understand that sight is our window to the world and losing it can be a profound and devastating experience. That’s why the Astellas Ophthalmics team puts the people affected by eye diseases that cause permanent vision loss at the heart of everything we do.
We are working to develop multiple potential treatments with the goal of slowing disease progression, protecting vision, preventing further loss, and the potential to restore vision.
